Fort Dodge licenses vaccine stem cells:
Fort Dodge Animal Health has gained the rights to an embryonic-derived stem cell line to evaluate it for use in the production of a viral vaccine. The cell line, called ebx, was developed by Vivalis, a biotechnology company based in Nantes, France. Vivalis was set up by Groupe Grimaud, which became the second-largest global specialist in avian genetics after acquiring Merial's avian genetics division in 2005 (Animal Pharm No 562, p 5). Franck Grimaud, chief executive of Vivalis, said: "We firmly believe that Vivalis' chicken and duck ebx cell lines could be an attractive alternative to embryonated eggs for the industrial production of viral vaccines."